首页> 外文OA文献 >Morphologic and genomic characterisation of the koala Chlamydia pneumoniae strain
【2h】

Morphologic and genomic characterisation of the koala Chlamydia pneumoniae strain

机译:考拉肺炎衣原体菌株的形态学和基因组学表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Chlamydia pneumoniae is a common human and animal pathogen associated with a wide range of upper and lower respiratory tract infections. In more recent years there has been increasing evidence to suggest a link between C. pneumoniae and chronic diseases in humans, including atherosclerosis, stroke and Alzheimer’s disease. C. pneumoniae human strains show little genetic variation, indicating that the human-derived strain originated from a common ancestor in the recent past. Despite extensive information on the genetics and morphology processes of the human strain, knowledge concerning many other hosts (including marsupials, amphibians, reptiles and equines) remains virtually unexplored. The koala (Phascolarctos cinereus) is a native Australian marsupial under threat due to habitat loss, predation and disease. Koalas are very susceptible to chlamydial infections, most commonly affecting the conjunctiva, urogenital tract and/or respiratory tract. To address this gap in the literature, the present study (i) provides a detailed description of the morphologic and genomic architecture of the C. pneumoniae koala (and human) strain, and shows that the koala strain is microscopically, developmentally and genetically distinct from the C. pneumoniae human strain, and (ii) examines the genetic relationship of geographically diverse C. pneumoniae isolates from human, marsupial, amphibian, reptilian and equine hosts, and identifies two distinct lineages that have arisen from animal-to-human cross species transmissions. Chapter One of this thesis explores the scientific problem and aims of this study, while Chapter Two provides a detailed literature review of the background in this field of work. Chapter Three, the first results chapter, describes the morphology and developmental stages of C. pneumoniae koala isolate LPCoLN, as revealed by fluorescence and transmission electron microscopy. The profile of this isolate, when cultured in HEp-2 human epithelial cells, was quite different to the human AR39 isolate. Koala LPCoLN inclusions were larger; the elementary bodies did not have the characteristic pear-shaped appearance, and the developmental cycle was completed within a shorter period of time (as confirmed by quantitative real-time PCR). These in vitro findings might reflect biological differences between koala LPCoLN and human AR39 in vivo. Chapter Four describes the complete genome sequence of the koala respiratory pathogen, C. pneumoniae LPCoLN. This is the first animal isolate of C. pneumoniae to be fully-sequenced. The genome sequence provides new insights into genomic ‘plasticity’ (organisation), evolution and biology of koala LPCoLN, relative to four complete C. pneumoniae human genomes (AR39, CWL029, J138 and TW183). Koala LPCoLN contains a plasmid that is not shared with any of the human isolates, there is evidence of gene loss in nucleotide salvage pathways, and there are 10 hot spot genomic regions of variation that were previously not identified in the C. pneumoniae human genomes. Sequence (partial-length) from a second, independent, wild koala isolate (EBB) at several gene loci confirmed that the koala LPCoLN isolate was representative of a koala C. pneumoniae strain. The combined sequence data provides evidence that the C. pneumoniae animal (koala LPCoLN) genome is ancestral to the C. pneumoniae human genomes and that human infections may have originated from zoonotic infections. Chapter Five examines key genome components of the five C. pneumoniae genomes in more detail. This analysis reveals genomic features that are shared by and/or contribute to the broad ecological adaptability and evolution of C. pneumoniae. This analysis resulted in the identification of 65 gene sequences for further analysis of intraspecific variation, and revealed some interesting differences, including fragmentation, truncation and gene decay (loss of redundant ancestral traits). This study provides valuable insights into metabolic diversity, adaptation and evolution of C. pneumoniae. Chapter Six utilises a subset of 23 target genes identified from the previous genomic comparisons and makes a significant contribution to our understanding of genetic variability among C. pneumoniae human (11) and animal (6 amphibian, 5 reptilian, 1 equine and 7 marsupial hosts) isolates. It has been shown that the animal isolates are genetically diverse, unlike the human isolates that are virtually clonal. More convincing evidence that C. pneumoniae originated in animals and recently (in the last few hundred thousand years) crossed host species to infect humans is provided in this study. It is proposed that two animal-to-human cross species events have occurred in the context of the results, one evident by the nearly clonal human genotype circulating in the world today, and the other by a more animal-like genotype apparent in Indigenous Australians. Taken together, these data indicate that the C. pneumoniae koala LPCoLN isolate has morphologic and genomic characteristics that are distinct from the human isolates. These differences may affect the survival and activity of the C. pneumoniae koala pathogen in its natural host, in vivo. This study, by utilising the genetic diversity of C. pneumoniae, identified new genetic markers for distinguishing human and animal isolates. However, not all C. pneumoniae isolates were genetically diverse; in fact, several isolates were highly conserved, if not identical in sequence (i.e. Australian marsupials) emphasising that at some stage in the evolution of this pathogen, there has been an adaptation/s to a particular host, providing some stability in the genome. The outcomes of this study by experimental and bioinformatic approaches have significantly enhanced our knowledge of the biology of this pathogen and will advance opportunities for the investigation of novel vaccine targets, antimicrobial therapy, or blocking of pathogenic pathways.
机译:肺炎衣原体是常见的人类和动物病原体,与多种上,下呼吸道感染有关。近年来,越来越多的证据表明肺炎衣原体与人类慢性疾病之间的联系,包括动脉粥样硬化,中风和阿尔茨海默氏病。肺炎衣原体的人类菌株几乎没有遗传变异,这表明人类起源的菌株是近来起源于共同祖先的。尽管有关人类毒株的遗传学和形态学过程的信息广泛,但有关许多其他宿主(包括有袋动物,两栖动物,爬行动物和马类)的知识实际上仍未得到开发。考拉(Phascolarctos cinereus)是由于栖息地丧失,捕食和疾病而受到威胁的澳大利亚本土有袋动物。考拉对衣原体感染非常敏感,最常影响结膜,泌尿生殖道和/或呼吸道。为了弥补文献中的空白,本研究(i)对肺炎衣原体考拉(和人类)菌株的形态和基因组结构进行了详细描述,并表明考拉菌株在显微镜,发育和遗传上与(ii)检查来自人类,有袋动物,两栖动物,爬行动物和马宿主的地理上不同的肺炎衣原体分离株的遗传关系,并鉴定出从动物到人的跨物种产生的两个不同谱系传输。本论文的第一章探讨了本研究的科学问题和研究目的,而第二章则提供了有关该工作背景的详细文献综述。第三章,第一章结果,描述了肺炎衣原体考拉分离液LPCoLN的形态和发育阶段,通过荧光和透射电镜观察。当在HEp-2人上皮细胞中培养时,该分离株的概况与人AR39分离株完全不同。考拉LPCoLN夹杂物较大;基本体没有特征性的梨形外观,并且发育周期在较短时间内完成(通过定量实时PCR证实)。这些体外发现可能反映了考拉LPCoLN和人类AR39在体内的生物学差异。第四章介绍了考拉呼吸道病原体肺炎衣原体LPCoLN的完整基因组序列。这是第一个被完全测序的肺炎衣原体动物分离株。相对于四个完整的肺炎衣原体人类基因组(AR39,CWL029,J138和TW183),基因组序列为考拉LPCoLN的基因组“可塑性”(组织),进化和生物学提供了新的见识。考拉LPCoLN包含一个与任何人类分离株均不共享的质粒,有证据表明核苷酸挽救途径中存在基因缺失,并且有10个热点基因组变异区域,以前在肺炎衣原体人类基因组中未发现。来自数个基因位点的第二个独立的野生考拉分离株(EBB)的序列(部分长度)证实了考拉LPCoLN分离株是考拉肺炎克雷伯氏菌菌株的代表。组合的序列数据提供了证据,证明肺炎衣原体动物(考拉LPCoLN)基因组是肺炎衣原体人类基因组的祖先,并且人类感染可能源于人畜共患病感染。第五章更详细地研究了肺炎衣原体的五个基因组的关键基因组组成。该分析揭示了肺炎衣原体广泛的生态适应性和进化所共有和/或对其贡献的基因组特征。这项分析导致鉴定出65种基因序列以进一步分析种内变异,并揭示了一些有趣的差异,包括片段化,截短和基因衰变(冗余祖先性状的丧失)。这项研究为肺炎衣原体的代谢多样性,适应性和进化提供了有价值的见解。第六章利用了从以前的基因组比较中鉴定出的23个靶基因的子集,对我们对肺炎衣原体人(11个)和动物(6个两栖动物,5个爬行动物,1个马和7个有袋动物宿主)的遗传变异性的理解做出了重要贡献。隔离株。已经表明,动物分离株在遗传上是多样的,这与实际上是克隆的人类分离株不同。这项研究提供了更有说服力的证据,表明肺炎衣原体来源于动物,最近(近几十万年来)越过宿主物种感染人类。建议在结果的背景下发生两次动物与人类的跨物种事件,一个事件通过当今世界上流行的近乎克隆的人类基因型来证明,而另一个则通过澳大利亚土著人的一种更像动物的基因型来证明。 。在一起,这些数据表明肺炎衣原体考拉LPCoLN分离株具有与人类分离株不同的形态和基因组特征。这些差异可能会影响肺炎衣原体考拉病原体在其自然宿主体内的存活和活性。这项研究通过利用肺炎衣原体的遗传多样性,确定了用于区分人和动物分离株的新遗传标记。但是,并不是所有的肺炎衣原体分离株在基因上都是多样化的。实际上,几个分离株是高度保守的,即使序列上不相同(即澳大利亚有袋动物),也强调了在该病原体进化的某个阶段,已经对特定宿主进行了适应,从而在基因组中提供了一定的稳定性。通过实验和生物信息学方法进行的这项研究的结果已大大增强了我们对这种病原体生物学的认识,并将为研究新型疫苗靶标,抗微生物治疗或阻断病原体途径提供机会。

著录项

  • 作者

    Mitchell Candice Melissa;

  • 作者单位
  • 年度 2010
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号